Back to ALNY
VANGUARD GROUP INC ALNY Position History
Alnylam Pharmaceuticals, Inc. • Healthcare
Quarters held
21
Latest value
$82.4M
Q4 2025
Peak value
$5.7B
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $15.1M |
| Q1 2025 | $16.2M |
| Q1 2025 | $3.4B |
| Q1 2025 | $8.4M |
| Q1 2025 | $50.5M |
| Q2 2025 | $19M |
| Q2 2025 | $20.1M |
| Q2 2025 | $4.2B |
| Q2 2025 | $11.1M |
| Q2 2025 | $63.9M |
| Q3 2025 | $5.7B |
| Q3 2025 | $28.9M |
| Q3 2025 | $352.8M |
| Q3 2025 | $912 |
| Q3 2025 | $92.3M |
| Q3 2025 | $27.2M |
| Q4 2025 | $24.4M |
| Q4 2025 | $25.7M |
| Q4 2025 | $4.9B |
| Q4 2025 | $327.6M |
| Q4 2025 | $82.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $82.4M | 207.3K | — | — |
| Q4 2025 | $327.6M | 823.8K | — | — |
| Q4 2025 | $4.9B | 12.40M | — | — |
| Q4 2025 | $25.7M | 64.6K | — | — |
| Q4 2025 | $24.4M | 61.3K | — | — |
| Q3 2025 | $27.2M | 59.6K | — | — |
| Q3 2025 | $92.3M | 202.5K | — | — |
| Q3 2025 | $912 | 2 | — | — |
| Q3 2025 | $352.8M | 773.6K | — | — |
| Q3 2025 | $28.9M | 63.3K | — | — |
| Q3 2025 | $5.7B | 12.47M | — | — |
| Q2 2025 | $63.9M | 195.9K | — | — |
| Q2 2025 | $11.1M | 34.0K | — | — |
| Q2 2025 | $4.2B | 12.95M | — | — |
| Q2 2025 | $20.1M | 61.6K | — | — |
| Q2 2025 | $19M | 58.4K | — | — |
| Q1 2025 | $50.5M | 187.1K | — | — |
| Q1 2025 | $8.4M | 31.1K | — | — |
| Q1 2025 | $3.4B | 12.72M | — | — |
| Q1 2025 | $16.2M | 60.0K | — | — |
| Q1 2025 | $15.1M | 56.1K | — | — |
Other funds holding ALNY
$1.8B
$1.8B
$1.6B
$1.6B
$1.4B
$1.3B
$1.1B
$1.1B